Article · 3 May 2019
Conference abstractPublished 9 Dec 2013
Evaluation of classical and marketed ayurvedic antidiabetic drug/formulations in type 2 diabetics
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Diabetes is rapidly emerging as a major health care problem and prevalence of type 2 diabetes has increased greatly over the past decade and it is found difficult to treat effectively in the long term. We observe that majority of patients are overweight or obese and will be unable to achieve or sustain near normoglycaemia with modern anti diabetic agents; a sizeable proportion of patients will eventually require Ayurveda therapy to maintain long-term glycaemic control, either as single herb/formulation or in conjunction with modern oral antidiabetic therapy. 21.5% general public have the first choice to treat diabetic in Ayurveda and Seventy three percentage of diabetic patients prefer effective Ayurveda medicine for their treatment either as food supplements or as drug. Today's Ayurveda clinicians are presented with an extensive range of single herb and formulation for type 2 diabetes. Therefore one observational study was conducted in NRIADD, Kolkota to evaluate the clinical outcome of commonly used classical and marketed ayurvedic antidiabetic drug/formulations in between July 2012 to June 2013 . The selection of initial drug/formulation are based on a clinical parameters like-Agni(digestive fire), Prakruti (constitution), Ahara shakti(digestive power) , Vyayama shakti(Physical strength) and biochemical assessment of the patient and safety considerations . Oral antidiabetic agents should be initiated at a low dose and titrated up according to glycaemic response, as judged by measurement of glycosylated haemoglobin (HbA1c) concentration, supplemented in some patients by self monitoring of capillary blood glucose. The commonly prescribed single herb are Karela (Momordica charantia)and Mesasringi (Gymnema sylvestre). The Other Poly herbal compounds are Amree- plus granules(AIMIL), Diabecon(Himalaya), Madhurakshaka(Dabur),Madhumehantak(Nutri),Zpter(Solumiks),Diabind(IND), Vasanta kusumakar Rasa, Triphala Churna, Chandraprava Vati. These main classes include agents that stimulate insulin secretion (Gymnema sylvestre), reduce hepatic glucose production (Katuki), delay digestion and absorption of intestinal carbohydrate (Karela) or improve insulin action (Chandraprava vati). We are confirmed drug?s clinical efficacy by targeting postprandial hyperglycaemia. Our Preliminary observational data suggesting that Amree-plus granules(AIMIL) may provide better glycaemic control . Some Ayurvedic Practitioner prescribing Triphala churna in prediabetic individuals having non alcoholic fatty liver . However, intensive lifestyle intervention can be more effective along with the Ayurveda drug/formulations.
Subjects
Alternative & Palliative CareAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2015
Antidiabetic properties of GTF – 231, an ayurvedic formulation studied in high fat diet fed-low dose STZ induced experimental type 2 diabetes in rats
Research article · 2008
Standardization of marketed ayurvedic formulations containing Shatavari and Ashwagandha
Research article · 12 Aug 2021
Evaluation of antidiabetic activity of some marketed polyherbal formulations in alloxan induced diabetic rat
Conference abstract · 2017
Controlled clinical study of an Ayurvedic anti-diabetic formulation BGR-34 tablets for its efficacy and safety in patients with diabetes mellitus
More from this journal
The newest in Alternative & Integrative Medicine.
Article · 6 Jan 2026
Integrative Anti-stress and Sleep-promoting Actions of Kombucha and Adaptogenic Herbs
Article · 29 Nov 2025
Ayurveda: Holistic Metabolic Syndrome Management
Article · 29 Nov 2025
Integrative Chronic Pain Management: A Holistic Approach
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAlternative & Integrative Medicine
- SubjectAlternative & Palliative Care
- BylineArticles whose byline prints “Ashok Kumar Panda”
- BylineArticles whose byline prints “Jayram Hazra”
- BylineArticles whose byline prints “Debajyoti Das”
- BylineArticles whose byline prints “Achinta Mitra”
- BylineArticles whose byline prints “Rohit Kuamr Rawate”

